UltraGreen Cardiac Technologies Launches Partnership with LifeSignals to Expand Access to Advanced Wearable Cardiac Monitoring Biosensors Globally

new york, 21 April 2026 /PRNewswire/ — UltraGreen Cardiac Technologies, a business unit of UltraGreen.ai (“UltraGreen” or the “Company”), a global leader in digital health solutions, today announced a strategic partnership with LifeSignals, a leader in wearable biosensor technology, to globally distribute LifeSignals’ advanced cardiac wearable monitoring biosensors.

Under the agreement, Ultragreen Cardiac Technologies will lead the distribution of LifeSignals’ 1AXe and 2AYe cardiac monitoring biosensors, expanding access to disposable, 2-channel devices designed for hospital systems, cardiology practices and independent clinical trial facilities (IDTFs) enabled through the UbiqVue™ Holter software platform.

These solutions will be commercialized Ultragreen Cardiac TechnologiesThe company’s dedicated platform for cardiac monitoring and digital health solutions.

Addressing the increasing need for monitoring in cardiology and after surgery

Heart disease remains the leading cause of morbidity, with millions of patients affected by heart rhythm disorders, including atrial fibrillation and other arrhythmias. The increasing prevalence of these conditions due to aging populations and the increasing burden of chronic diseases has placed sustained pressure on cardiology services and clinical capacity worldwide.

Wearable, continuous heart monitoring plays a critical role in enabling earlier detection, improved workflow efficiency for providers, and better long-term management of cardiovascular conditions.

Ultragreen will offer customers flexible commercial models, including:

• Direct hardware supply, enabling hospital systems, IDTFs and practices to manage data interpretation internally.

• Integrated service model, combining hardware, cloud-based software, and access to trained ECG technicians to support workflow optimization, reporting, and scalability.

Strategic expansion of UltraGreen.ai’s digital health ecosystem

“This partnership reflects our commitment to building clinically relevant, data-driven platforms that solve real capacity challenges in health care systems globally,” said Ravi Sajwan, CEO of Ultragreen. “In addition to addressing the increasing demand of cardiology, wearable monitoring plays an important role in patient care.”

About Ultragreen and Ultragreen Cardiac Technologies

UltraGreen.ai Ltd. is a digital health and global leader in fluorescence-guided surgery, developing data-driven platforms to support clinical decision making and improve patient outcomes across care pathways.